Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...
This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...
Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...
A recalled spinach artichoke dip is a Class II risk, and updates have been issued for the recall of chocolate nut and wafer ...
Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...
The Health and Human Services Secretary directed the FDA to consider eliminating a pathway that allowed companies to "self-affirm" whether their ingredients are safe for consumption.
"We need to pass legislation that ensures patients have better access to FDA-approved, non-opioid pain management ...
A study published in November in the American Journal of Clinical Pathology that Emerson co-authored validated the analyzer against the Sysmex XN Automated Hematology System and found that CytoChip's ...
Trump admin's FDA medical product review units remain protected from cuts, while Marty Makary awaits confirmation as ...
Pharmalittle: We’re reading about Lilly and Roche weight loss drugs, FDA and compounders, and more
Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...
Operators and retailers are undertaking FSMA pilots with RFID tags on products packed into cases, which then serves as the ...
Dr. Paul Offit, an FDA vaccine adviser, says the Biden administration made missteps in rolling out boosters, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback